Rahul Singh

Rahul Singh is an accomplished professional with extensive experience in respiratory patient care and marketing within the pharmaceutical industry. Currently serving as the Head of Respiratory Patient Care at Cipla since June 2013, Rahul manages the Breathefree initiative and oversees a significant portfolio that includes leading brands like Foracort and Duolin. Previous roles at Cipla include Sr Marketing Head and Group Product Manager, where Rahul demonstrated expertise in demand generation, patient onboarding, and market development. Prior to Cipla, Rahul held positions at Glenmark Pharmaceuticals and Themis Medicare Ltd, focusing on diverse therapeutic areas, and began a career in pharmacovigilance at Tata Consultancy Services. Educational credentials include a Bachelor of Pharmacy from the University of Mumbai and an MBA in Marketing from DY Patil University.